Sponsor study identifier
observational
3
1 country
1
Study Start
January 1, 2012
Actual (reported)Primary Completion
November 8, 2018
Actual (reported)Study Completion
November 8, 2018
Actual (reported)Reversible cerebral vasoconstriction syndrome (RCVS) is characterized by severe, unusual headaches associated with multifocal segmental vasoconstriction of the intracerebral arteries. In addition to headache, focal neurological deficit and/or seizures are quite frequently described, but anterograde amnesia seems to but extremely rare. Indeed, to date, only one case of RCVS associated with transient global amnesia (TGA) has been published. In case of an atypical presentation of TG, associated with brutal headaches, it is important not to ignore an assocation with RCVS because management, treatment, evolution and prognosis are different. Indeed, TGA is a monophasic phenomenon of less than 24 hours duration, without associated complications, which does not require any particular treatment. On the other hand, RCVS, although most often of excellent prognosis, can have severe complications such as intracerebral hemorrhage, subarachnoid hemorrhage, posterior reversible encephalopathy syndrome and cerebral infarction. In order to limit headaches and potential complications, RCVS require special management, including symptomatic treatments for headaches, complete rest, removal of precipitin factors and introduction of calcium channel blockers for a few weeks. This study aim to described three cases of patient who presented with concomitant TGA and RCVS, and to discuss pathogenic mechanism which may be similar in both these pathologies.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
November 8, 2018
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 1, 2012
Actual (reported)November 8, 2018
Actual (reported)November 8, 2018
Actual (reported)November 9, 2018
Actual (reported)November 13, 2018
Actual (reported)Occurrence of concomitant TGA and proven RCVS
Occurrence of concomitant transient global amnesia (TGA) and proven Reversible cerebral vasoconstriction syndrome (RCVS)
1 day
Patients with a proven or probable RCVS concomittant with certain transient global amnesia in the Neurology department of Gui de Chauliac and Lariboisière hospitals
Uhmontpellier
Montpellier, 34295, France
Nicolas Gaillard, MD
University Hospital, Montpellier
3 participants (actual enrollment reported by the registry).
First Submitted
November 9, 2018
First Posted
November 13, 2018
Study Start
January 1, 2012
Actual (reported)Contact the study team to confirm eligibility.
Primary Completion
November 8, 2018
Actual (reported)Study Completion
November 8, 2018
Actual (reported)Last Updated
August 12, 2019
Record last verified: 2018-11
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: